Your browser doesn't support javascript.
loading
A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study.
O'Cearbhaill, Roisin E; Deng, Wei; Chen, Lee-May; Lucci, Joseph A; Behbakht, Kian; Spirtos, Nick M; Muller, Carolyn Y; Benigno, Benedict B; Powell, Matthew A; Berry, Emily; Tewari, Krishnansu S; Hanjani, Parviz; Lankes, Heather A; Aghajanian, Carol; Sabbatini, Paul J.
Afiliação
  • O'Cearbhaill RE; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: ocearbhr@mskcc.org.
  • Deng W; NRG Oncology Statistics & Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA. Electronic address: wdeng@gogstats.org.
  • Chen LM; University of California San Francisco, San Francisco, CA, USA. Electronic address: lee-may.chen@ucsfmedctr.org.
  • Lucci JA; The University of Texas Health Science Center at Houston, Houston, TX, USA. Electronic address: Joseph.A.Lucci@uth.tmc.edu.
  • Behbakht K; Rush University Medical Center, Chicago, IL, USA. Electronic address: kian.behbakht@ucdenver.edu.
  • Spirtos NM; Women's Cancer Center of Nevada, Las Vegas, NV, USA. Electronic address: nspirtos@wccenter.com.
  • Muller CY; Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, Albuquerque, NM, USA. Electronic address: cmuller@salud.unm.edu.
  • Benigno BB; University Gynecologic Oncology, Atlanta, GA, USA. Electronic address: benedict.benigno@ugynonc.com.
  • Powell MA; Washington University School of Medicine, St. Louis, MO, USA. Electronic address: powellm@wudosis.wustl.edu.
  • Berry E; Northwestern Medicine Prentice Women's Hospital, Chicago, IL, USA. Electronic address: https://dremilyberry.com.
  • Tewari KS; University of California Irvine Medical Center, Orange, CA, USA. Electronic address: ktewari@uci.edu.
  • Hanjani P; Hanjani Institute for Gynecologic Oncology, Abington Memorial Hospital, Abington, PA, USA. Electronic address: phanjani@aol.com.
  • Lankes HA; NRG Oncology, Operations Center-Philadelphia East, Philadelphia PA and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Electronic address: LankesH@NRGOncology.org.
  • Aghajanian C; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: aghajanc@mskcc.org.
  • Sabbatini PJ; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: sabbatip@mskcc.org.
Gynecol Oncol ; 155(3): 393-399, 2019 12.
Article em En | MEDLINE | ID: mdl-31653510
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Adjuvantes Imunológicos / Vacinas Conjugadas / Vacinas Anticâncer / Neoplasias das Tubas Uterinas / Carcinoma Epitelial do Ovário Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Adjuvantes Imunológicos / Vacinas Conjugadas / Vacinas Anticâncer / Neoplasias das Tubas Uterinas / Carcinoma Epitelial do Ovário Idioma: En Ano de publicação: 2019 Tipo de documento: Article